Elite Pharmaceuticals Inc (ELTP)

[WeeZuhl]

jour, the terminology is fuzzy


The phrase "oral abuse" is commonly used to refer to chewing and also commonly used to refer to swallowing extra whole pills. There is no official nomenclature at this point. It creates a lot of confusion because those are obviously separate components of abuse deterrent technology. I wish FDA and company literature would use more specific language, such as "chewing" and "overdose."

ELTP 2 bead antagonist ADF tech will easily qualify for IV, snorting, and chewing ADF label for every opioid agonist with any time-release characteristic. No known company is within 10 years of marketing an effective overdose ADF.